| MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience 1999 · antioxidant vitamin supplement · Men and women aged 40–80 at elevated risk of coronary heart disease death due to prior coronary heart disease, occlusive non-coronary arterial disease, diabetes mellitus, or treated hypertension | 250 mg | 20 mg | 5 years | — |
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 2001 · Antioxidants · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye | 500 mg | 15 mg | 8 years | — |
| Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13 2004 · antioxidants alone · Adults aged 55–81 years with age-related macular degeneration categories 1–4 or other AREDS ocular eligibility; participants in AMD categories 2–4 were eligible for this arm, and category 1 participants could also receive antioxidants | 500 mg | 15 mg | 339 weeks | — |
| Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35 2013 · Antioxidants · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4) | 500 mg | 15 mg | 339 weeks | — |
| No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38 2014 · antioxidants · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years | 500 mg | 15 mg | 9 years | — |
| Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial 1997 · vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C was common at baseline | 120 mg | 6 mg | 2 years | — |
| "The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants 1999 · antioxidant vitamins and minerals supplementation · Women aged 35 to 60 years and men aged 45 to 60 years, without a stated condition | 120 mg | 6 mg | 8 years | — |
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 2001 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye | 500 mg | 15 mg | 8 years | — |
| Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13 2004 · antioxidants plus zinc · Adults aged 55–81 years with AMD categories 2–4 and AREDS ocular eligibility | 500 mg | 15 mg | 339 weeks | — |
| The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals 2004 · antioxidant supplement group · French women aged 35–60 and men aged 45–60 in the general population | 120 mg | 6 mg | 2739 days | — |
| Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels? 2005 · daily antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years | 120 mg | 6 mg | 2739 days | — |
| [The SU.VI.MAX study, a randomized, placebo-controlled trial on the effects of antioxidant vitamins and minerals on health] 2006 · antioxidant supplementation · Middle-aged adults in the general population | 120 mg | 6 mg | 2738 days | — |
| Antioxidant supplementation increases the risk of skin cancers in women but not in men 2007 · antioxidant group · French adult women and men in a general-population primary-prevention trial | 120 mg | 6 mg | 2738 days | — |
| Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study 2010 · antioxidant supplementation · French women aged 35–60 years and men aged 45–60 years | 120 mg | 6 mg | 2738 days | — |
| Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35 2013 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4) | 500 mg | 15 mg | 339 weeks | — |
| No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38 2014 · antioxidants plus zinc · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years | 500 mg | 15 mg | 9 years | — |
| Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial 1997 · combination of trace elements and vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C, zinc and selenium were common at baseline | 120 mg | 6 mg | 2 years | — |
| Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants 1998 · active medication · Adults with colorectal polyps; age range and sex not stated | 150 mg | 15 mg | 3 years | — |
| Acute effects of ozone on pulmonary function of cyclists receiving antioxidant supplements 1998 · supplementation group · Amateur cyclists; age and sex not reported; no condition stated | 650 mg | 15 mg | 90 days | 12 |
| The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract 2002 · vitamin group · Adult American and English outpatients with early age-related cataract | 750 mg | 18 mg | 3 years | — |
| Antioxidant supplementation and respiratory functions among workers exposed to high levels of ozone 1998 · supplement group · Mexico City street workers exposed to high ozone levels; age and sex not stated | 650 mg | 15 mg | 26 weeks | — |
| [Study of the antioxidant drug "Karinat" in patients with chronic atrophic gastritis] 2004 · Karinat · Patients with chronic multifocal atrophic gastritis | 60 mg | 5 mg | 26 weeks | 34 |
| [Study of an antioxidant dietary supplement "Karinat" in patients with benign breast disease] 2004 · Karinat · Patients with benign breast disease, including mastopathy | 60 mg | 5 mg | 26 weeks | 33 |
| Increased vitamin plasma levels in Swedish military personnel treated with nutrients prior to automatic weapon training 2011 · Nutrients (active treatment) · Normally hearing Swedish military personnel, officers and military academy trainees, ages 18 and older, undergoing weapons training | 500 mg | 18 mg | 2 days | 31 |
| Changes in ventilatory threshold at high altitude: effect of antioxidants 2006 · antioxidant (AO) supplement group · Physically fit males aged 25 ± 5 years exposed to high altitude at 4300 m | 500 mg | 12 mg | 5 weeks | — |
| French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial 2011 · antioxidant supplementation · French adults aged 45–60 years enrolled in the SU.VI.MAX study | 120 mg | 6 mg | 2922 days | — |
| Combination oral antioxidant supplementation reduces blood pressure 1997 · antioxidants · Hypertensive and normotensive adult outpatients; 21 were attending for hypertension treatment and 17 were normotensive outpatients with minor gastrointestinal complaints. | 500 mg | 30 mg | 8 weeks | — |
| Supplementation with antioxidants prior to bone marrow transplantation 1997 · BMT(+) · Bone marrow transplant patients receiving conditioning therapy | 450 mg | 45 mg | 3 weeks | 16 |
| GLV supplements increased plasma beta-carotene, vitamin C, zinc and hemoglobin in young healthy adults 2006 · standard meal with tablets · Young healthy adults; sex and age range not reported | 150 mg | 10 mg | 1 day | 4 |
| Antioxidants, Helicobacter pylori and stomach cancer in Venezuela 1996 · Treatment 1 · People with precancerous stomach lesions, including chronic gastritis, chronic atrophic gastritis, intestinal metaplasia or dysplasia; age and sex not specified | 750 mg | 18 mg | 7 days | — |
| Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network 1996 · V (vitamins) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized | 120 mg | 6 mg | 26 weeks | — |
| Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters 1997 · vitamin group · Hospitalized adults older than 65 years; baseline vitamin C deficiency was common | 120 mg | 6 mg | 2 years | — |
| Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX 1997 · vitamins · Institutionalized elderly subjects in long-term hospital or nursing-home care | 120 mg | 6 mg | 1 year | — |
| Effects of Multivitamin, Multimineral and Phytonutrient Supplementation on Nutrient Status and Biomarkers of Heart Health Risk in a Russian Population: A Randomized, Double Blind, Placebo Controlled Study 2018 · VMP (Nutrilite Double X™) · Generally healthy adults aged 40–70 years in Moscow with low habitual recommended-food intake (recommended food score <12), predominantly women; no chronic diseases | 180 mg | 3 mg | 8 weeks | 60 |
| [Effects of vitamins E, C and beta-carotene on DNA damage] 1999 · trial group · Healthy men aged 50–59 years | 100 mg | 25 mg | 20 weeks | 50 |
| Antioxidant vitamins and low-density-lipoprotein oxidation 1993 · antioxidant supplementation · Adults; ages and health conditions not stated | 900 mg | 18 mg | 26 weeks | 22 |
| Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trial 1992 · active treatment · Patients with recurrent non-gallstone pancreatitis | 540 mg | 9,000 IU | 10 weeks | 20 |
| Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study 2014 · softgel half-dose (single softgel) · Healthy adults aged 18–45 years, women and men | 226 mg | 8.6 mg | 1 day | 15 |
| Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study 2014 · softgel full-dose (two softgels) · Healthy adults aged 18–45 years, women and men | 452 mg | 17.2 mg | 1 day | 15 |
| Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study 2014 · tablet full-dose (four tablets) · Healthy adults aged 18–45 years, women and men | 452 mg | 17.2 mg | 1 day | 15 |
| Antioxidant supplementation enhances neutrophil oxidative burst in trained runners following prolonged exercise 2003 · antioxidant vitamin supplement · Healthy trained endurance runners; 6 men and 6 women, mean age 30.1 years | 900 mg | 18 mg | 7 days | 12 |
| Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation 1993 · combined antioxidant therapy · adult male subjects; age and health condition not specified | 1 g | 30 mg | 90 days | 12 |
| Effects of antioxidant supplementation on blood cyclosporin A and glomerular filtration rate in renal transplant recipients 2005 · antioxidant supplementation phase · renal transplant recipients taking cyclosporin A; age and sex not reported | 500 mg | 6 mg | 26 weeks | 10 |
| Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: a randomized, factorial design, placebo-controlled trial 1999 · Antioxidant vitamins · Men aged 30–49 with plasma homocysteine concentration ≥8.34 μmol/L | 150 mg | 9 mg | 8 weeks | — |
| Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study 2001 · Antioxidant supplementation group · Women aged 35–60 years and men aged 45–60 years in France, general population | 120 mg | 6 mg | 2 years | — |
| Diet supplementation with vitamin E, vitamin C and beta-carotene cocktail enhances basal neutrophil antioxidant enzymes in athletes 2002 · antioxidant-supplemented group · Sportsmen; age and health condition not specified | 1 g | 30 mg | 90 days | — |
| Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function 2003 · group B [high dose of supplement] · Patients with cystic fibrosis; age and sex not specified | 300 mg | 25 mg | 8 weeks | — |
| Changes in serum retinol, alpha-tocopherol, vitamin C, carotenoids, xinc and selenium after micronutrient supplementation during alcohol rehabilitation 2003 · micronutrient supplement group · Alcohol-dependent patients aged 20 to 60 years without severe liver disease, hospitalized for alcohol rehabilitation | 120 mg | 6 mg | 3 weeks | — |
| Antioxidant diet supplementation influences blood iron status in endurance athletes 2004 · antioxidant supplemented · Amateur trained male endurance athletes | 1 g | 30 mg | 90 days | — |
| Response of blood cell antioxidant enzyme defences to antioxidant diet supplementation and to intense exercise 2006 · antioxidant supplemented · Amateur trained male athletes; age and health condition not specified | 1 g | 30 mg | 90 days | — |
| Antioxidant supplementation lowers exercise-induced oxidative stress in young overweight adults 2006 · overweight adults receiving antioxidant treatment · overweight adults aged 18–30 years | 500 mg | 10 mg | 8 weeks | — |
| Antioxidant supplementation lowers exercise-induced oxidative stress in young overweight adults 2006 · normal-weight adults receiving antioxidant treatment · normal-weight adults aged 18–30 years | 500 mg | 10 mg | 8 weeks | — |
| Multivitamin-mineral supplementation prevents lipid peroxidation during "the Marathon des Sables" 2007 · Supplemented group · Athletes participating in the Marathon des Sables; age and sex not specified | 150 mg | 4.8 mg | 4 weeks | — |
| Antioxidant diet supplementation enhances aerobic performance in amateur sportsmen 2007 · antioxidant-supplemented group · Amateur male athletes; age and health condition not stated | 1 g | 30 mg | 90 days | — |
| [Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person] 2008 · Group 1 · Adults aged 60–75 years; elderly participants | 300 mg | 16.7 mg | 16 weeks | — |
| [Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person] 2008 · Group 2 · Adults aged 60–75 years; elderly participants | 300 mg | 8.4 mg | 16 weeks | — |
| [Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person] 2008 · Group 3 · Adults aged 60–75 years; elderly participants | 300 mg | 5.6 mg | 16 weeks | — |
| Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults 2009 · Normal-weight antioxidant-treated (N-AOX) · Apparently healthy men and women aged 18–30 years with BMI <25 kg/m² | 500 mg | 10 mg | 8 weeks | — |
| Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults 2009 · Overweight antioxidant-treated (O-AOX) · Apparently healthy men and women aged 18–30 years with BMI ≥25 kg/m² | 500 mg | 10 mg | 8 weeks | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS antioxidants only · Adults aged 55–80 with early or more advanced age-related macular degeneration | 500 mg | 15 mg | 5 years | — |
| Effects of an antioxidant vitamin mixture on lipid peroxidation at rest and postexercise 1993 · antioxidant vitamin group · Young healthy males, mean age 25.0 years | 1 g | 30 mg | 6 weeks | — |
| Antioxidants, Helicobacter pylori and stomach cancer in Venezuela 1996 · Treatment 2 · People with precancerous stomach lesions, including chronic gastritis, chronic atrophic gastritis, intestinal metaplasia or dysplasia; age and sex not specified | 650 mg | 15 mg | 7 days | — |
| Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network 1996 · VT (vitamins associated with trace elements) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized | 120 mg | 6 mg | 26 weeks | — |
| Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease 1997 · mid-dose · Patients with established cardiovascular disease | 500 mg | 12 mg | 12 weeks | — |
| Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease 1997 · high dose · Patients with established cardiovascular disease | 1 g | 24 mg | 12 weeks | — |
| Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters 1997 · mineral and vitamin group · Hospitalized adults older than 65 years; baseline deficiencies of vitamin C, zinc and selenium were common | 120 mg | 6 mg | 2 years | — |
| Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX 1997 · trace elements associated with vitamins · Institutionalized elderly subjects in long-term hospital or nursing-home care | 120 mg | 6 mg | 1 year | — |
| Effects of supplementation with a combination of antioxidant vitamins and trace elements, at nutritional doses, on biochemical indicators and markers of the antioxidant system in adult subjects 1998 · supplementation group · Adult men aged 45–60 years and women aged 35–60 years | 120 mg | 6 mg | 26 weeks | — |
| Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers 1998 · antioxidants without n-3 fatty acids · adult male smokers with hyperlipidaemia | 150 mg | 15 mg | 6 weeks | — |
| Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3) 1996 · intervention group · Patients with suspected acute myocardial infarction; age and sex not stated | 1 g | 25 mg | 4 weeks | 63 |
| Folate levels determine effect of antioxidant supplementation on micronuclei in subjects with cardiovascular risk 2004 · antioxidant-supplemented group · Middle-aged men: myocardial infarction survivors younger than 50 and healthy controls | 100 mg | 6 mg | 12 weeks | 53 |
| Antioxidant micronutrients improve intrinsic and UV-induced apoptosis of human lymphocytes particularly in elderly people 2011 · Y2 · Healthy young adults aged 18–22 years | 500 mg | 1.5 mg | 60 days | 45 |
| Antioxidant micronutrients improve intrinsic and UV-induced apoptosis of human lymphocytes particularly in elderly people 2011 · O2 · Healthy older adults aged 60–75 years | 500 mg | 1.5 mg | 60 days | 45 |
| [Effect of multiple micronutrients supplementation on anti-oxidative activity and oxidized DNA damage of lymphocytes in children] 2005 · supplement group · Chinese children aged 9–11 years, described as healthy and living in a rural area | 300 mg | 1 mg | 8 weeks | 41 |
| Antioxidant micronutrients improve intrinsic and UV-induced apoptosis of human lymphocytes particularly in elderly people 2011 · C2 · Healthy children aged 8–10 years | 300 mg | 1 mg | 60 days | 40 |
| Effects of antioxidant supplementation on platelet function: a randomized pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status 1991 · antioxidant-supplemented men · Men with low antioxidant status | 600 mg | 27 mg | 150 days | 39 |
| Increase in oxidation resistance of atherogenic serum lipoproteins following antioxidant supplementation: a randomized double-blind placebo-controlled clinical trial 1994 · supplemented group · Healthy men aged 30–58 years who smoked 15–40 cigarettes per day | 400 mg | 30 mg | 90 days | 20 |
| Oxidative stress in humans during work at moderate altitude 1999 · antioxidant mixture group · U.S. Marines engaged in moderate-altitude cold-weather field training; age and sex not reported | 500 mg | — | 4 weeks | 15 |
| Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: a randomized, factorial design, placebo-controlled trial 1999 · B vitamins with antioxidant vitamins · Men aged 30–49 with plasma homocysteine concentration ≥8.34 μmol/L | 150 mg | 9 mg | 8 weeks | — |
| Effect of antioxidant supplementation on urine and blood markers of oxidative stress during extended moderate-altitude training 1999 · antioxidant supplement (S) group · US Marine Corps volunteers undergoing 14 days of winter training at approximately 2700 m | 500 mg | 20,000 IU | 2 weeks | — |
| Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX Study 2005 · antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years | 120 mg | 6 mg | 2738 days | — |
| Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration 2007 · antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration | 500 mg | 15 mg | 2433 days | — |
| Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trial 2010 · antioxidant micronutrient combination · Patients with a history of sporadic colorectal adenoma; age and sex not specified | 1 g | 24 mg | 120 days | — |
| Effects of 6 weeks of n-3 fatty acids and antioxidant mixture on lipid peroxidation at rest and postexercise 2011 · LCPUFA plus antioxidant mixture · Judoists; age and sex not reported; no diagnosed condition stated | 60 mg | 6 mg | 6 weeks | — |
| Antioxidant micronutrient supplementation increases erythrocyte membrane fluidity in adults from a rural Chinese community 2011 · A2 · Children; age range and sex not reported | 300 mg | 1 mg | 60 days | — |
| Antioxidant micronutrient supplementation increases erythrocyte membrane fluidity in adults from a rural Chinese community 2011 · B2 · Young people; age range and sex not reported | 500 mg | 1.5 mg | 60 days | — |
| Antioxidant micronutrient supplementation increases erythrocyte membrane fluidity in adults from a rural Chinese community 2011 · C2 · Elderly subjects; age range and sex not reported | 500 mg | 1.5 mg | 60 days | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS antioxidants plus zinc · Adults aged 55–80 with early or more advanced age-related macular degeneration | 500 mg | 15 mg | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 500 mg | 15 mg | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 500 mg | 15 mg | 5 years | — |
| Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants 1997 · antioxidants · male smokers with combined hyperlipidemia | 150 mg | 15 mg | 6 weeks | — |
| Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants 1997 · omega-3 FAs and antioxidants · male smokers with combined hyperlipidemia | 150 mg | 15 mg | 6 weeks | — |
| Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers 1998 · n-3 fatty acids with antioxidants · adult male smokers with hyperlipidaemia | 150 mg | 15 mg | 6 weeks | — |
| Supplementation with antioxidants prior to bone marrow transplantation 1997 · Healthy control group · Healthy controls | 450 mg | 45 mg | 3 weeks | 10 |
| Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration 2007 · antioxidants · Adults aged 55–80 with age-related macular degeneration | 500 mg | 15 mg | 2433 days | — |